Epidermal growth factor receptor (EGFR) is critical for controlling the growth and survival of epithelial cells and is often targeted therapeutically in epithelial malignancies, including non-small cell lung cancer (NSCLC). This evidence concerns the gene EGFR and non-small cell lung carcinoma.